Authors
Latest:
The Ethics of a Donated Brain: An Abuse of AutonomyIs forcing a school shooter to donate his brain to scientific study unethical?
Latest:
Managing Treatment-Resistant Depression: Tips for the Outpatient PsychiatristHere's how embracing a comprehensive, patient-centered approach and staying informed about emerging treatments can help mental health professionals make a difference in the lives of patients with TRD.
Latest:
The Impact of Cannabis Use on Medication Nonadherence in PsychiatryCannabis use disorder and nonadherence: How can we best educate patients?
Latest:
Psychiatrists’ Response to Human Trafficking: An UpdateHow to help individuals caught in human trafficking: person-centered, culturally humble, trauma-informed care.
Latest:
Schizophrenia: Current Treatment Options and ConsiderationsHow do we find the right treatments for our patients with schizophrenia at every step of their journey?
Latest:
Telling Humanity’s Brain Story: Insights From Brain CapitalWhich innovations can improve measurement, technology, investment, and public policy surrounding brain health?
Latest:
How Cities Can Boost Brain CapitalIn a shock-prone world, city-level thinking is a new approach to optimizing the brain health and brain skills of citizens.
Latest:
Brain Science Must Be on COP 26 AgendaAs the COP-26 (Conference of the Parties) gets ready to convene to discuss climate change, it is crucial for them to consider brain science.
Latest:
Music Therapy for Inpatient Psychiatric Care in the 1990sFaced with the trend toward shorter length of stay in inpatient psychiatric units, practitioners and patients in need of care face dramatic changes in treatment.
Latest:
What To Do in San DiegoThe president of the San Diego Psychiatric Society gives us a glimpse into the city for the upcoming 2022 Annual Psychiatric Times World CME Conference.
Latest:
Eight Best Practices for Medical Malpractice DefenseExperts share their best practices and tips.
Latest:
Current Treatments for Cannabis Use DisorderWhile there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
Latest:
Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical TrialResearch reveals that IV haloperidol and ziprasidone are safe for treating delirium in patients that are critically ill, showing minimal impact on QTc intervals.
Latest:
Emotion and Cognitive Control: An Essential Partnership for Adaptive BehaviorDisruptions to cognitive control, as well as to emotional processes, are implicated in a wide range of psychiatric disorders.
Latest:
Potential Success With DBS: Reducing Stigma and Addressing Unmet NeedNeurosurgeon Brian Kopell, MD, discusses the potential of deep brain stimulation for treatment-resistant depression, aiming to reduce stigma and improve patient care.
Latest:
Attention to Attention is What You Need: Artificial Intelligence and MedicineHere's how medical practitioners and researchers can influence AI reasoning and influence in the future of AI development and deployment.
Latest:
What’s Perfusion Got to Do With It?Combination therapy of TMS and ketamine could enhance brain perfusion and neuroplasticity.
Latest:
Buprenorphine and Its Therapeutic Potential in Psychiatric DisordersResearchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.
Latest:
Legal and Ethical Issues in Emergency PsychiatryEmergency psychiatry navigates complex ethical dilemmas, balancing patient safety, autonomy, and confidentiality in high-stakes situations.
Latest:
Special Considerations for SGM Youth OnlineOnline environments have revolutionized the lives of young SGM individuals, but also created unforeseen issues...
Latest:
The Dawn of a New Era for SchizophreniaLearn more about the latest advancements in schizophrenia treatment and the ongoing battle against stigma during Mental Health Awareness Month.
Latest:
Using Collaborative Care to Improve Outcomes for Patients With Schizophrenia and COVID-19Individuals with schizophrenia have experienced an increase in psychiatric, medical, and treatment risks because of the COVID-19 pandemic.
Latest:
Psychosis in the Patient With COVID-19: An Emerging Psychopathology?"This pandemic represents an unprecedented time that requires a psychiatrist’s vigilance in identifying patients at risk for COVID-19–induced psychosis."
Latest:
THC and Adolescents: An Overlooked Issue in Youth Mental HealthRegular THC use in adolescence is not a benign activity—it can have life-changing consequences. Here’s what you need to know.
Latest:
Perspectives on Excited Delirium and KetamineParenteral ketamine is commonly used to manage agitation that is deemed severe and obstructive to necessary medical evaluation and treatment. But what does this suggest about the relationship between medicine and society?
Latest:
Brain Capital: An Emerging Investment OpportunityBrain Capital: a fresh approach to technologies and investing.
Latest:
Pioneering Change in Juvenile Correctional PsychiatryElizabeth Lowenhaupt, MD, CCHP, shares her insights and experiences on correctional psychiatry and juvenile mental health as she looks toward the future of the field.
Latest:
Beyond the Neurotransmitter: We Were Trained to See the Forest for the TreesPsychopharmacology, while an essential tool, is only one of those tools.
